Beta Bionics shareholders elect directors, ratify Ernst & Young at annual meeting

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

• low

  Shareholders elected Sean D. Carney (98.1% of votes cast, 68.8% of shares outstanding) and Christy Jones (82.7% of votes cast, 58.0% of shares outstanding) as Class I directors to serve until 2029.

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
• low

  Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 99.9% approval (36,011,432 for, 41,527 against, 8,089 abstentions), representing 80.8% of shares outstanding.

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
• low

  Meeting achieved quorum with 36,061,048 shares (80.9%) of 44,561,695 outstanding shares represented in person or by proxy.

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →